placeholder image
P. J. Hergenrother All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 
    Neurooncol Adv. 2023
  • Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 
    British Journal of Cancer. 2023
  • The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma. 
    Melanoma Research. 2023
    • Contact
    full name
  • P. J. Hergenrother
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration